Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
暂无分享，去创建一个
M. Parmentier | C. Durinx | G. Opdenakker | P. Proost | A. Lambeir | J. Neyts | J. Van Damme | S. Liekens | E. Schutyser | J. Damme | A. Billiau | S. Struyf | M. Detheux | A. Wuyts | P. Menten | P. Maudgal | Marc Parmentier | Christine Durinx | Johan Neyts | Sandra Liekens | Prabhat C. Maudgal | Alfons Billiau | Johan Neyts